![PDF) Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized PDF) Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized](https://www.researchgate.net/publication/360184916/figure/fig1/AS:1148929597026305@1650937570902/Participant-flow-diagram-LTF-lost-to-follow-up-ITT-intent-to-treat-mITT-modified_Q320.jpg)
PDF) Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized
![PDF) Double-Blind Clinical Trials of Oral Triptans Vs Other Classes of Acute Migraine Medication — A Review PDF) Double-Blind Clinical Trials of Oral Triptans Vs Other Classes of Acute Migraine Medication — A Review](https://i1.rgstatic.net/publication/8608042_Double-Blind_Clinical_Trials_of_Oral_Triptans_Vs_Other_Classes_of_Acute_Migraine_Medication_-_A_Review/links/5ea73b0ba6fdccd79459d09a/largepreview.png)
PDF) Double-Blind Clinical Trials of Oral Triptans Vs Other Classes of Acute Migraine Medication — A Review
![PDF) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry PDF) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry](https://i1.rgstatic.net/publication/374585839_Triptan_non-response_in_specialized_headache_care_cross-sectional_data_from_the_DMKG_Headache_Registry/links/6526008ec64260390bde9f0f/largepreview.png)
PDF) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry
![PDF) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry PDF) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry](https://www.researchgate.net/publication/374585839/figure/fig4/AS:11431281206263544@1700621963246/Frequency-of-response-and-reasons-for-failure-of-specific-triptans-A-Triptan-responders_Q320.jpg)
PDF) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry
![PDF) Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis PDF) Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis](https://i1.rgstatic.net/publication/7968961_Costs_and_Utilization_of_Triptan_Users_Who_Receive_Drug_Prophylaxis_for_Migraine_Versus_Triptan_Users_Who_Do_Not_Receive_Drug_Prophylaxis/links/5650d35308aefe619b155756/largepreview.png)
PDF) Costs and Utilization of Triptan Users Who Receive Drug Prophylaxis for Migraine Versus Triptan Users Who Do Not Receive Drug Prophylaxis
![PDF) Review of the Available Evidence on oral Sumatriptan in Adults and Children for the Treatment of Acute Migraine Attacks and Proposal for Inclusion FOR THE WHO MODEL LIST OF ESSENTIAL MEDICINES ( PDF) Review of the Available Evidence on oral Sumatriptan in Adults and Children for the Treatment of Acute Migraine Attacks and Proposal for Inclusion FOR THE WHO MODEL LIST OF ESSENTIAL MEDICINES (](https://www.researchgate.net/profile/Francesco-Nonino/publication/366158586/figure/tbl5/AS:11431281106353853@1670629325301/European-retail-price-of-triptans-paracetamol-and-aspirin_Q320.jpg)
PDF) Review of the Available Evidence on oral Sumatriptan in Adults and Children for the Treatment of Acute Migraine Attacks and Proposal for Inclusion FOR THE WHO MODEL LIST OF ESSENTIAL MEDICINES (
![PDF) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry PDF) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry](https://www.researchgate.net/publication/374585839/figure/fig1/AS:11431281206281834@1700621962720/Triptan-failure-and-no-failure-subgroups_Q320.jpg)
PDF) Triptan non-response in specialized headache care: cross-sectional data from the DMKG Headache Registry
![PDF) A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine PDF) A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine](https://i1.rgstatic.net/publication/303832194_A_phase_IIb_randomized_double-blind_placebo-controlled_trial_of_ubrogepant_for_the_acute_treatment_of_migraine/links/59dceb5d0f7e9b2120321d69/largepreview.png)
PDF) A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
![PDF) Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches: Headache PDF) Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches: Headache](https://i1.rgstatic.net/publication/330745597_Efficacy_of_ADAM_Zolmitriptan_for_the_Acute_Treatment_of_Difficult-to-Treat_Migraine_Headaches_Headache/links/5c5256ad299bf12be3efe3ee/largepreview.png)